AQEMIA: Drug Discovery Pipeline Company Raises $38 Million
By Amit Chowdhry ● Dec 13, 2024
AQEMIA, a biotechnology company that teaches atomic-scale physics to a generative AI (GenAI) for inventing new medicines, announced two significant milestones: $100 million in total funding and the beginning of a global expansion, starting with London (United Kingdom). This new round is led by Cathay Innovation, followed by historical investors Wendel, Bpifrance Large Venture, Eurazeo, and Elaia.